Hematopoietic Stem Cell-containing Autologous Blood Reinfusion for Bone Marrow Protection in Cervical Cancer Patients
Clinical trial NCT05401175 · RECRUITING
Trial details
- NCT number
- NCT05401175
- Sponsor
- Chongqing University Cancer Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-13
- Primary completion
- 2027-04-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.